CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and ...

CASGEVY approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT) in Switzerland and Canada- -45 authorized treat ...

Researchers compared the efficacy of various treatment modalities for cutaneous squamous cell carcinoma in situ.